Free Trial

Windtree Therapeutics (WINT) SEC Filings & 10K Form

Windtree Therapeutics logo
$1.64 -0.06 (-3.53%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$1.66 +0.03 (+1.52%)
As of 03/27/2025 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Windtree Therapeutics SEC Filings

DateFilerForm TypeView
03/25/2025
4:24 PM
Windtree Therapeutics (Filer)
Form 8-K/A
03/24/2025
3:38 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
7:10 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:20 PM
Windtree Therapeutics (Filer)
Form 8-K/A
02/14/2025
3:44 PM
ARMISTICE CAPITAL, LLC (Filed by)
Windtree Therapeutics (Subject)
Form SCHEDULE 13G/A
02/03/2025
4:20 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
4:05 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:09 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:25 PM
Windtree Therapeutics (Filer)
Form DEF 14A
01/08/2025
7:05 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
5:03 AM
Windtree Therapeutics (Filer)
Form PRE 14A
12/05/2024
6:12 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
7:02 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:43 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
3:46 PM
Windtree Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/15/2024
3:32 PM
Windtree Therapeutics (Filer)
Form 8-K/A
11/15/2024
3:30 PM
Windtree Therapeutics (Filer)
Form NT 10-Q
11/14/2024
6:15 PM
Lind Global Fund II LP (Filed by)
Windtree Therapeutics (Subject)
Form SC 13G/A
11/14/2024
7:53 AM
Flynn James E (Filed by)
Windtree Therapeutics (Subject)
Form SC 13G/A
11/14/2024
7:01 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
6:46 AM
Fraser Craig (Reporting)
Windtree Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
4:27 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
4:28 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
7:55 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:22 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
7:05 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
4:21 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
4:26 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
11:15 PM
Windtree Therapeutics (Filer)
Form EFFECT
09/03/2024
11:15 PM
Windtree Therapeutics (Filer)
Form EFFECT
09/03/2024
8:09 AM
Windtree Therapeutics (Filer)
Form 424B5
09/03/2024
8:10 AM
Windtree Therapeutics (Filer)
Form 424B5
09/03/2024
6:26 AM
Windtree Therapeutics (Filer)
Form ARS
09/03/2024
6:22 AM
Windtree Therapeutics (Filer)
Form DEF 14A
08/23/2024
3:15 PM
Windtree Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/21/2024
3:55 PM
Windtree Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/20/2024
7:44 PM
Windtree Therapeutics (Filer)
Form PRE 14A
08/20/2024
3:30 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
3:24 PM
PELLETIER SAUNDRA L (Reporting)
Windtree Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/29/2024
7:33 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
3:07 PM
Windtree Therapeutics (Filer)
Form RW
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
07/24/2024
4:27 PM
Fraser Craig (Reporting)
Windtree Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
4:28 PM
Simonson Steven (Reporting)
Windtree Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
8:25 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:53 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
8:11 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
3:59 PM
Windtree Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:41 AM
Windtree Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/21/2024
11:15 PM
Windtree Therapeutics (Filer)
Form EFFECT
04/17/2024
4:03 PM
Windtree Therapeutics (Filer)
Form S-3/A
04/17/2024
6:30 AM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
4:16 PM
Windtree Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/10/2024
3:37 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
3:33 PM
Windtree Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
4:29 PM
Windtree Therapeutics (Filer)
Form NT 10-K
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:WINT) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners